Cue Biopharma, Inc. (CUE) Shareholders’ equity 2018–2025
Cue Biopharma, Inc. (CUE) shareholders’ equity at each fiscal year-end, per SEC filings.
$26.4MFY2025 · since FY2018: $34.0M → $26.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $26.4M | +51.0% |
| FY2024 | $17.5M | -52.8% |
| FY2023 | $37.1M | -43.5% |
| FY2022 | $65.7M | +0.3% |
| FY2021 | $65.5M | -17.0% |
| FY2020 | $78.9M | +44.6% |
| FY2019 | $54.6M | +60.7% |
| FY2018 | $34.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice